Department of Biotechnology | Indian Institute Of Technology Madras , Chennai
team

D Karunagaran

Emeritus Professor

Ph.D., Sri Krishnadevaraya University

M.Phil., University of Madras

Block 1, BT 401

044 2257 4126

karuna[at]iitm[.]ac[.]in

Lab: Block 1, BT 005

  • Cancer Biology:
  • Mechanisms of Apoptosis activated by anticancer agents
  • Signaling by growth factors
  • NF-kappa B signaling

  1. Chandrasekaran KS, Sathyanarayanan A, Karunagaran D. (2017). "miR-214 activates TP53but suppresses the expression of RELA, CTNNB1, and STAT3 in human cervical andcolorectal cancer cells. ", Cell BiochemFunct., 35, pp. 464-471..
  2. . "Karunagaran, D. and Goodwin Jinesh(2005) Biotechnological approaches in the detection and treatment of cancer. In “Advances in Biotechnology” Ed. P. C. Trivedi, Agrobios (India), Jodhpur".
  3. . "Karunagaran, D. and Goodwin Jinesh (2008). TGF-β, Smads and Cervical Cancer. In Transforming Growth Factor-Beta in Cancer Therapy Volume II Cancer Drug Discovery and Development Jakowlew, Sonia (Ed.) The Humana Press, Inc., NJ, USA.".
  4. . "Karunagaran, D. (2003) Relevance of Apoptosis to Cancer. In: Biotechnology: Emerging Trends. Joseph Selvin et al. (eds). Biotech Publishers, New Delhi".
  5. . "Karunagaran, D., and Bharat Aggarwal (2003) Transcription factors as targets for drug development “In Pathomechanisms- New trends in drug research: Molecular mechanisms and new trends in drug development” Ed. Gyorgy Keri and Istvan Toth, Taylor and Francis, London and New York".